BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34940797)

  • 1. The molecular pathogenesis of repeat expansion diseases.
    Fujino Y; Nagai Y
    Biochem Soc Trans; 2022 Feb; 50(1):119-134. PubMed ID: 34940797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat-associated non-AUG translation in neuromuscular diseases: mechanisms and therapeutic insights.
    Fujino Y; Mori K; Nagai Y
    J Biochem; 2023 Mar; 173(4):273-281. PubMed ID: 36748359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of RNA-induced toxicity in CAG repeat disorders.
    Nalavade R; Griesche N; Ryan DP; Hildebrand S; Krauss S
    Cell Death Dis; 2013 Aug; 4(8):e752. PubMed ID: 23907466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGG Repeats in the 5'UTR of FMR1 RNA Regulate Translation of Other RNAs Localized in the Same RNA Granules.
    Rovozzo R; Korza G; Baker MW; Li M; Bhattacharyya A; Barbarese E; Carson JH
    PLoS One; 2016; 11(12):e0168204. PubMed ID: 28005950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome.
    Todd PK; Oh SY; Krans A; He F; Sellier C; Frazer M; Renoux AJ; Chen KC; Scaglione KM; Basrur V; Elenitoba-Johnson K; Vonsattel JP; Louis ED; Sutton MA; Taylor JP; Mills RE; Charlet-Berguerand N; Paulson HL
    Neuron; 2013 May; 78(3):440-55. PubMed ID: 23602499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.
    Verma AK; Khan E; Mishra SK; Kumar A
    Mol Neurobiol; 2022 Mar; 59(3):1992-2007. PubMed ID: 35040038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (Dys)function Follows Form: Nucleic Acid Structure, Repeat Expansion, and Disease Pathology in
    Zhao X; Usdin K
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
    Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
    Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperine Modulates Protein Mediated Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome through Interacting Expanded CGG Repeat (r(CGG)
    Verma AK; Khan E; Mishra SK; Jain N; Kumar A
    ACS Chem Neurosci; 2019 Aug; 10(8):3778-3788. PubMed ID: 31264835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PolyQ-independent toxicity associated with novel translational products from CAG repeat expansions.
    Rudich P; Watkins S; Lamitina T
    PLoS One; 2020; 15(4):e0227464. PubMed ID: 32240172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAG repeat RNA as an auxiliary toxic agent in polyglutamine disorders.
    Wojciechowska M; Krzyzosiak WJ
    RNA Biol; 2011; 8(4):565-71. PubMed ID: 21593608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat-associated non-AUG translation induces cytoplasmic aggregation of CAG repeat-containing RNAs.
    Das MR; Chang Y; Anderson R; Saunders RA; Zhang N; Tomberlin CP; Vale RD; Jain A
    Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2215071120. PubMed ID: 36623192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
    Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
    Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription-associated R-loop formation across the human FMR1 CGG-repeat region.
    Loomis EW; Sanz LA; Chédin F; Hagerman PJ
    PLoS Genet; 2014 Apr; 10(4):e1004294. PubMed ID: 24743386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Development for CGG Repeat Expansion-Associated Neurodegeneration.
    Xu K; Li Y; Allen EG; Jin P
    Front Cell Neurosci; 2021; 15():655568. PubMed ID: 34054431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of repeat-associated non-AUG translation in neurological microsatellite expansion disorders.
    Castelli LM; Huang WP; Lin YH; Chang KY; Hautbergue GM
    Biochem Soc Trans; 2021 Apr; 49(2):775-792. PubMed ID: 33729487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in
    Tekendo-Ngongang C; Grochowsky A; Solomon BD; Yano ST
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828275
    [No Abstract]   [Full Text] [Related]  

  • 19. Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies.
    Schwartz JL; Jones KL; Yeo GW
    Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):31-53. PubMed ID: 33172304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary structural choice of DNA and RNA associated with CGG/CCG trinucleotide repeat expansion rationalizes the RNA misprocessing in FXTAS.
    Ajjugal Y; Kolimi N; Rathinavelan T
    Sci Rep; 2021 Apr; 11(1):8163. PubMed ID: 33854084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.